Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q3 EPS of ($0.44), $0.08 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.